Clinical trials

  • DOSTARLIMAB for Endometrial cancer | Mismatch repair deficient endometrial cancer
  • DATOPOTAMAB DERUXTECAN for Non-small cell lung cancer
  • EFAVIRENZ for Alzheimer's Disease
  • Bevacizumab for Breast cancer | Hormone receptor-positive HER2-negative breast cancer | Estrogen receptor-positive breast cancer
  • EPCORITAMAB for Diffuse large B-cell lymphoma | High-grade B-cell lymphoma | Follicular lymphoma grade 3B
  • Lithium carbonate for Bipolar disorder type II
  • Nepafenac for Fuchs dystrophy
  • MESALAZINE for Ulcerative colitis
  • Mezigdomide for Relapsed or refractory multiple myeloma
  • ATEZOLIZUMAB for Non-small cell lung cancer (Stage IV)
  • PANITUMUMAB for Colon cancer | Colorectal cancer stage III | Colorectal cancer stage II
  • durvalumab for Small-cell lung cancer (limited stage)